Sio Gene Therapies, formerly known as Axovant, is a clinical-stage company with a singular focus on pushing the boundaries of gene therapy to develop treatments for debilitating neurodegenerative diseases, including GM1 gangliosidosis, Tay-Sachs/Sandhoff disease, and Parkinsonâ??s disease. Sio is leveraging its foundational scientific expertise built on decades of research, extensive collaborations with leading gene therapy institutes, and a flexible vector platform to liberate patients with debilitating diseases through the transformational power of gene therapies.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Sio Gene Therapies Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Sio Gene Therapies Inc market cap is $35.36M.
What is the 52-week high for Sio Gene Therapies Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Sio Gene Therapies Inc 52 week high is $0.50 as of September 08, 2025.
What is the 52-week low for Sio Gene Therapies Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Sio Gene Therapies Inc 52 week low is $0.25 as of September 08, 2025.
What is Sio Gene Therapies Inc stock price today?
Sio Gene Therapies Inc stock price today is $0.478.
What was Sio Gene Therapies Inc stock price yesterday?
Sio Gene Therapies Inc stock price yesterday was $0.47.
What is the PE ratio of Sio Gene Therapies Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Sio Gene Therapies Inc’s P/E ratio is -1.22.
What is the Price-to-Book ratio of Sio Gene Therapies Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Sio Gene Therapies Inc P/B ratio is 0.7837.
What is the 50-day moving average of Sio Gene Therapies Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Sio Gene Therapies Inc 50-day moving average is $0.3922.
